Market Analysis and Insights:- Global End Stage Renal Disease (ESRD) Drug Market
Global End Stage Renal Disease (ESRD) Drug Market Diagnosis Type (Blood Test, Urine Test, Imaging Test, Biopsy), Treatment Type (Supportive Care, Dialysis and Kidney Transplantation), Drugs Type (Lanthanum carbonate, , Diphenhydramine and Others), Dietary Supplement (Phosphorus Binders, Iron, Active Vitamin D, Vitamin B-complex & Folic Acid, Vitamin E), Route of Administration (Oral, Topical, Intravenous and Others), Distribution Channel (Online Pharmacy, Direct Tenders (Retailers and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Dialysis centres), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026
Market Analysis: Global End Stage Renal Disease (ESRD) Drug Market
Global end stage renal disease (ESRD) drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the increasing prevalence of diabetic nephropathy, genetic diseases, infection, traumatic injury, major surgery among others changing life style , development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth.
Get More Insight About the Global End Stage Renal Disease (ESRD) Drug Market, Request Sample@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=glo...
Market Definition: Global End Stage Renal Disease (ESRD) Drug Market
End stage renal disease (ESRD) is a stage of permanent renal failure where the kidney stops functioning normally and unable to remove waste or excess fluid from the blood. Kidneys are responsible for the vital functions that support the body such as excretion, balancing electrolytes and production of certain hormones. A patient with end-stage renal failure must receive kidney transplant or dialysis for a long-term survival.
Market Drivers
• Rising prevalence of kidney diseases, diabetes, hypertension and rapid growth in the geriatric population is driving the market growth
• Changing life style of the people across the world can also act as a market driver
• Development in the healthcare expenditure and the government support for the research & development for new and better treatment have fueled the market growth
• Increasing awareness amongst people about health and kidney disorders is also driving this market growth
Market Restraints
• Rising healthcare expenditure along high cost of dialysis and kidney transplantation can hamper the market growth
• Lack of awareness amongst people about dialysis and organ donation is hindering the market growth
• Disparities in the access to renal transplant therapy is also restricting the growth of this market
Know More About this Report @ https://www.databridgemarketresearch.com/reports/global-end-stage-r...

Segmentation: Global End Stage Renal Disease (ESRD) Drug Market
By Diagnosis
• Blood Test
• Urine Test
• Imaging Test
• Biopsy
By Treatment
• Supportive Care
• Dialysis
• Hemodialysis
• Peritoneal dialysis
• Kidney Transplantation
By Dietary Supplement
• Iron
• Active Vitamin D
• Phosphorus Binders
• Vitamin B-complex & Folic Acid Vitamin E
By Route of Administration
• Oral
• Intravenous
• Others
By Distribution Channel
• Online Pharmacy
• Direct Tenders
• Retailers
• Others
By End-Users
• Hospitals
• Homecare
• Specialty Clinics
• Dialysis centres
By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Turkey
o Russia
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Singapore
o Malaysia
o Thailand
o Indonesia
o Philippines
o Rest of Asia Pacific
• South America
o Brazil
o Rest of South America
• Middle East & Africa
o South Africa
o Rest of Middle East & Africa
Key Developments in the Market:
• In April 2019, Astellas Pharma Inc is developing roxadustat which is undergoingphase lll clinical trial for the treatment of anemia in adults with end stage renal disease (ESRD) on stable dialysis. Roxadustat, a HIF prolyl-hydroxylase inhibitor, is used to increase the production of erythropoietin which eventually stimulates the production of hemoglobin and red blood cells
• In February 2017, Amgen Inc received the FDA approval for Parsabiv (etelcalcetide) for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease on hemodialysis. Parsabiv (etelcalcetide) is a calcium-sensing receptor agonist and supplied as an injection for intravenous administration
Competitive Analysis:
Global end stage renal disease (ESRD) drug market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of end stage renal disease (ESRD) drug market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
The key market players in the global end stage renal disease (ESRD) drug market are Johnson & Johnson Services, Inc, Baxter, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Abbott, Pfizer Inc, Novartis AG, Bristol-Myers Squibb Company, Sanofi, AstraZeneca, Fresenius Medical Care AG & Co. KGaA, Keryx Biopharamceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Teva Pharmaceutical Industries Ltd., Bayer AG, Ionis Pharmaceuticals, Aevi Genomic Medicine, Inc, Humacyte, Inc, Astellas Pharma Inc, Amgen Inc and few others.
Research Methodology: Global End Stage Renal Disease (ESRD) Drug Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
Request for Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-end-stage...
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
• Current and future of global end stage renal disease (ESRD) drug market outlook in the developed and emerging markets.
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period.
• The latest developments, market shares, and strategies that are employed by the major market players.
Access Full report @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/gl...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]